Author:
Haghighian-Roudsari Arezoo,Khoshnazar Tahereh Alsadat Khoubbin,Ajami Marjan,Pourmoradian Samira
Abstract
Abstract
Background
World is currently challenging with Covid-19 pandemic. Nutritional status is a determinant factor in the treatment process and recovery for patients with Covid-19. Although a limited data is available about the effects of nutrition on this disease. Therefore, the aim of this study was to identify nutritional problems in patients recovering from Covid-19 before, during and after the disease.
Methods
This qualitative descriptive study was carried out based on the specified inclusion criteria through targeted sampling of 45 patients recovered from Covid-19, 2021–2022. In-depth semi-structured individual interviews were used to collect data. Interviews were recorded, transcribed and analyzed using qualitative content analysis method and MAXQDA Software.
Results
Based on the participants’ description of this stage, it can be reported that most of the individuals who were infected had no specific symptoms. Nutrition-linked problems in the main stage of the disease included troubles in tolerating foods and nutrition (e.g., fatty and solid foods), highly consumed foods in the main stage of the disease (e.g., beverages), individuals’ approaches to improve nutritional challenges (e.g., consumption of herbal teas and soft texture foods) and using supplements. The patients stated fewer nutritional problems after recovering from the disease. The most significant change included their desire to eat solid foods such as rice, bread, pasta and fast foods.
Conclusion
appropriate nutrition with medication can help accelerate the recovery process of the patients, especially hospitalized patients with further severe degrees of the illness.
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health,Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Medicine (miscellaneous)
Reference43 articles.
1. World Health Organization. Critical preparedness, readiness and response actions for COVID-19: interim guidance, 22 March 2020(No. WHO/2019-nCoV/Community_Actions/2020.3). World Health Organization; 2020.
2. https://covid19.who.int/region/emro/country/iran
3. Jaafarabadi M, Bagheri M, Shariat M, Raeisie K, Ranjbar A, Ghafoori F, Haghollahi F. The evaluation of clinical symptoms and underlying factors in infected patients with Covid-19. Tehran Univ Med J. 2021;78(10):668–77 http://tumj.tums.ac.ir/article-661-10932-en.html.
4. Mehraeen E, Najafi Z, Hayati B, Javaherian M, Rahimi S, Dadras O, SeyedAlinaghi S, Ghadimi M, Sabatier J-M. Current treatments and therapeutic options for COVID-19 patients: a systematic review. Infect Disord-Drug Targets (Formerly Curr Drug Targets-Infect Disord). 2022;22(1):62–73. https://doi.org/10.2174/1871526521666210726150435.
5. Jin Y-H, Cai L, Cheng Z-S, Cheng H, Deng T, Fan Y-P, Fang C, Huang D, Huang L-Q, Huang Q. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Mil Med Res. 2020;7(1):4. https://doi.org/10.1186/s40779-40020-40233-40776.